RxDoctor Payments Data

Kelly Carte, NP

Family · Huntington, WVNPI 1699268896

Payments from drug & device makers

$2,848in general payments, 2019–2025

Across 164 payments — averaging $17.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Otsuka America Pharmaceutical, Inc.$511
  • Alkermes, Inc.$247
  • Indivior Inc.$207
  • Lundbeck LLC$193
  • Axsome Therapeutics, Inc.$147
  • plus $443 from 10 others

What the payments were for

  • Food & beverage$2,848100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,848 in reported general payments places this provider in the 85th percentile of 1,507 family providers in West Virginia.

See all family providers in West Virginia

Medicare billing

Part B allowed, 2024
$17,915
Medicare patients
50
Services billed
275

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl26$51,670
RexultiBrexpiprazole16$21,574
Bupropion XlBupropion Hcl108$3,100
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl14$3,071
Aripiprazole67$2,143
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine59$2,127
Quetiapine Fumarate127$1,974
Venlafaxine Hcl ErVenlafaxine Hcl141$1,902
Desvenlafaxine Succinate ErDesvenlafaxine Succinate43$1,891
Vilazodone Hcl22$1,563
Olanzapine50$1,560
Alprazolam240$1,362
Fluoxetine Hcl69$1,322
Mirtazapine68$1,308
Buspirone Hcl109$1,118

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$1,100$51,67026 claims
Otsuka America Pharmaceutical, Inc.Rexulti$511$21,57416 claims
Lilly USA, LLCOlanzapine$17$1,56050 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,507 family providers in West Virginia.

Other family in Huntington

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →